G. Ahlin

Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions

K. Giacomini, R. Davis, P. Artursson, 2011, The Pharmacogenomics Journal.

Specific and general inhibitors of the three hepatic organic anion transporters OATP1B1 (SLCO1B1), OATP1B3 (SLCO1B3) and OATP2B1 (SLCO2B1)

P. Artursson, Anna Vildhede, M. Karlgren, 2010 .

Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines

Per Artursson, P. Artursson, A. Ungell, 2007, Drug Metabolism and Disposition.

Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.

Christel A. S. Bergström, P. Artursson, J. Karlsson, 2008, Journal of medicinal chemistry.

A Global Drug Inhibition Pattern for the Human ATP-Binding Cassette Transporter Breast Cancer Resistance Protein (ABCG2)

Ulf Norinder, Christel A. S. Bergström, Christel A S Bergström, 2007, Journal of Pharmacology and Experimental Therapeutics.

Endogenous Gene and Protein Expression of Drug-Transporting Proteins in Cell Lines Routinely Used in Drug Discovery Programs

M. Uhlén, C. Szigyarto, P. Artursson, 2009, Drug Metabolism and Disposition.

Measurement of Unbound Drug Exposure in Brain: Modeling of pH Partitioning Explains Diverging Results between the Brain Slice and Brain Homogenate Methods

Ulf Bredberg, Margareta Hammarlund-Udenaes, Fredrik Bergström, 2011, Drug Metabolism and Disposition.

In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions

Christel A. S. Bergström, P. Artursson, J. Palm, 2011, Pharmaceutical Research.

Expression of 36 drug transporter genes in human intestine, liver, kidney, and organotypic cell lines

Per Artursson, P. Artursson, A. Ungell, 2007 .